Chemical structure of TAK-906 Altos Therapeutics/Takeda D2/D3 receptor antagonist

peripherally-restricted D2/D3 antagonist

oral agent for gastroparesis in Ph. II

up to 100 mg PO BID

JPET, Clinical Pharmacology

Altos Therapeutics / Takeda, Cambridge

The Altos Therapeutics/Takeda D2/D3 receptor antagonist, TAK-906, is a peripherally-restricted, non-BBB penetrant molecule, targeting the stomach and vomiting center in the area postrema to treat gastroparesis. Gastroparesis is a chronic condition…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.